Grifols seeks looser terms in $5.3bn refi launch
Spanish pharmaceutical company Grifols is planning to take advantage of balmy market conditions with a refinancing package that will replace most of its outstanding debt. The package will consist of a $3bn term loan B in dollars, a $1.6bn TLB in euros and $1.25bn of senior secured bonds issued in euros.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: